Pharmafile Logo

CP Kelco UK Ltd

CP Kelco is the innovation leader in the production of polysaccharides by microbial fermentation, extraction from land and sea plants, and modification of cellulose-based raw materials. CP Kelco’s goal is to be the preferred partner for providing innovative products and solutions through the use of nature-based chemistry.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Cleeve Court, Cleeve Road, Leatherhead, Surrey, KT22 7UD
+44  (0) 1372 369 400

 Latest Content from PMHub 

How to Increase Engagement During Virtual Events

Tip #8 - Do you make sure to have a host for all your virtual events? Check our top 10 tips to increase engagement during virtual events: https://www.impetusdigital.com/2021/03/25/top-10-tips-to-increase-engagement-during-virtual-events/

Report gives insights to address gaps in HCP engagement

How does Pharma-HCP engagement need to evolve in today's digital landscape?

Cuttsy+Cuttsy campaign takes health literacy to the North Pole

Our 2022 Christmas campaign saw Santa’s agency elves creating tailored materials for patients. But were the examples guided by the principles of health literacy? Were they naughty or nice?

World-renowned creative icon Jeremy Perrott joins KVA

Press Releases | January 16, 2023 | KVA

KVA are excited to announce that Jeremy Perrott is joining the digital comms healthcare agency as a Board Advisor

Video: Strategic engagement case study

White Papers and Resources | January 13, 2023 | Inizio

Supporting the launch of a global vaccine with a programme of market research and strategic insights

Webcast: The virtual patient: How to use AI-powered conjoint to understand complex treatment decisions

White Papers and Resources | January 13, 2023 | Inizio

Watch to find out how a combination of virtual patients and artificial intelligence can help you to better understand physicians’ decision making processes.

Repurposing Off-Patent Drugs Through Crowd Funding

Savva Kerdemelidis, Founder & CEO of Crowd Funded Cures, explores the concepts of interventional pharmacoeconomics and pay-for-success contracts to fund new uses for off-patent drugs and other unmonopolizable therapies. 

The impact of mindset on digital product success: Download our new whitepaper

Press Releases | January 11, 2023 | Graphite Digital

Six months on from releasing our research report, we reflect on the themes raised and offer practical advice on how contradictions can be overcome to enable digital success in pharma...

SCIRIS ANNOUNCES APPOINTMENT OF NEW CEO

Porterhouse extends a very warm welcome to Isaac Batley

Virtual Tools for Promoting Diversity in Pharma and Clinical Trials

It is no secret that Pharma (still) has a major diversity problem.